pscprep.ai
BlogPricingAbout

Explore category

All State PCS Exams

Exam hubs, syllabus, strategy — and public PYQ attempt + insight pages.

National exam

UPSC CSE

PYQs, mocks, AI planner — Prelims Paper I & II.

State PCS

UPSCAvailableUPSC Civil Services (CSE)BPSCAvailableBihar (BPSC - CCE)CGPSCAvailableChhattisgarh (CGPSC - SSE)MPPSCAvailableMadhya Pradesh (MPPSC - SSE)MPSCAvailableMaharashtra (MPSC - Rajyaseva)OPSCAvailableOdisha (OPSC - OCS)RPSCAvailableRajasthan (RPSC - RAS)TNPSCAvailableTamil Nadu (TNPSC - Group 1)UPPSCAvailableUttar Pradesh (UPPSC - PCS)WBCSAvailableWest Bengal (WBCS)HPSCComing soonHaryana (HPSC)JKPSCComing soonJammu and Kashmir (JKPSC)JPSCComing soonJharkhand (JPSC)KPSCComing soonKarnataka (KPSC)PPSCComing soonPunjab (PPSC)UKPSCComing soonUttarakhand (UKPSC)
Current AffairsToolsFor InstitutesDashboard
UPSCState PCSCurrent AffairsToolsPricingBlogAboutInstitutes
pscprep.ai

Smart exam prep for UPSC and State PCS aspirants with adaptive planning, daily current affairs, and exam-focused practice.

Get the weekly digest

Top current affairs + exam tips, every Monday morning.

Explore

BlogUPSCState PCS ExamsExam ScheduleAttempt PYQPYQ trendsCurrent AffairsToolsPricingAboutContactLog inFor Institutes

Connect With Us

hello@pscprep.aiFollow on FacebookFollow on Instagram

Get the App

Google PlayApp Store — coming soon

Copyright © 2026 PSCPrep.ai. All rights reserved.

Legal business name: EXAMBEES

Privacy PolicyTerms and ConditionsCancellation/Refund Policy
Current AffairsScience & Technology

Could hantavirus be the new emerging pathogen in Kerala?

Monday, 11 May 20269 min read1,698 words122

Get the weekly digest

Top current affairs + exam tips, every Monday morning.

📝 AI-generated analysis for exam preparation. This is original educational content curated for competitive exam aspirants.

Science & TechnologyDeep Analysishealth medicinegovernance reformsbiodiversityschemes programs

In this article

ContextBackground & Historical EvolutionKey Points & FactsMulti-Dimensional AnalysisWay Forward

Context

The Institute of Advanced Virology (IAV) at Thonnakkal, Thiruvananthapuram, has acquired Polymerase Chain Reaction (PCR) testing facility for confirmatory diagnosis of hantavirus infections in Kerala. This development comes as virologists and clinicians in the State raise concerns about hantavirus (scientifically known as Orthohantavirus) potentially being a new emerging pathogen. Kerala's Health department has acknowledged that hantavirus could be responsible for a significant proportion of acute febrile illnesses with renal syndrome and thrombocytopenia (lowered platelet count), currently attributed to suspected leptospirosis. The clinical symptoms of hantavirus-induced Hemorrhagic Fever with Renal Syndrome (HFRS) and leptospirosis are nearly identical, making differential diagnosis without targeted serology tests extremely difficult. The IAV has initiated PCR testing of clinical samples from Thiruvananthapuram Medical College Hospital, though no positive cases have been detected so far. The virus causes two major diseases in humans: Hantavirus Pulmonary Syndrome and HFRS, with the latter being more common in India. HFRS due to hantavirus carries a reported mortality rate of up to 15% in Southeast Asia, though no human-to-human transmission has been documented.

Background & Historical Evolution

The history of hantavirus detection in Kerala spans nearly three decades, with initial evidence emerging in 1999. Hantaviruses belong to the family Hantaviridae and are zoonotic viruses transmitted primarily through inhalation of aerosolized particles from the urine, saliva, or droppings of infected rodents.[/GK] In 1999, serological and clinical evidence of hantavirus infection in India was first documented when 30 serum samples from Kochi were sent to the Laboratory of Clinical and Epidemiological Virology at the University of Leuven, Belgium, for testing. Of these, two cases were found to be hanta positive in both IgM and IgG antibody tests. The hanta serotypes identified were Seol virus (SEOV) and Puumala virus (PUUV). Puumala virus is typically associated with Nephropathia Epidemica, a milder form of HFRS common in Europe, while Seoul virus has a wider global distribution.[/GK]

In 2014, Kerala reported one probable case of hantavirus-induced HFRS that clinically mimicked leptospirosis, but confirmatory diagnosis was not available at that time. The State carries a huge annual burden of leptospirosis, with farming, sanitation work, and monsoon floods driving the spillover of the pathogen from animals to humans. Rodent-borne hantaviruses are also circulating in the same agro-ecological zones, making human exposure to these viruses highly plausible.

A significant development occurred in December 2025 when researchers Chandy et al published a study in which serum samples from 216 febrile patients presenting at Lisie Hospital, Kochi, were tested for anti-orthohantavirus IgM and IgG antibodies. The findings revealed that 16.2% of samples were positive for anti-orthohantavirus IgM and 11.57% for IgG antibodies, while both IgM and IgG were detected in 4.63% of samples, indicating widespread virus exposure in the population. The One Health approach, recognizing the interconnection between human, animal, and environmental health, has been promoted by WHO, FAO, and WOAH since 2008 to address such zoonotic disease emergence.[/GK]

Key Points & Facts

Diagnostic Infrastructure Development:

  • Institute of Advanced Virology (IAV), Thonnakkal, Thiruvananthapuram has acquired PCR testing facility for confirmatory diagnosis of hantavirus infections
  • Previously, access to both serology tests (IgM ELISA) and molecular diagnostic tests (PCR) for hantavirus was limited across Kerala and the entire country
  • IAV has initiated routine PCR testing of clinical samples from Thiruvananthapuram MCH for hantavirus

Historical Evidence of Hantavirus in Kerala:

  • First documented in 1999: 2 out of 30 serum samples from Kochi tested positive for hantavirus antibodies (IgM and IgG)
  • Serotypes identified: Seol virus (SEOV) and Puumala virus (PUUV)
  • One probable hantavirus-induced HFRS case reported in 2014 (mimicked leptospirosis)

Seroprevalence Data:

  • December 2025 study by Chandy et al at Lisie Hospital, Kochi:
  • 216 febrile patients tested for anti-orthohantavirus antibodies
  • 16.2% positive for IgM antibodies
  • 11.57% positive for IgG antibodies
  • 4.63% positive for both IgM and IgG

Disease Characteristics:

  • Hantavirus (Orthohantavirus) causes two major diseases: Hantavirus Pulmonary Syndrome and Hemorrhagic Fever with Renal Syndrome (HFRS)
  • HFRS is more common in India
  • Mortality rate: up to 15% in Southeast Asia
  • No human-to-human transmission documented
  • Clinical symptoms identical to leptospirosis: high-grade fever with myalgia, lowered platelet count, acute kidney injury, hemorrhagic manifestations

Key Stakeholders:

  • Dr. R. Aravind, Head of Infectious Diseases, Government Medical College, Thiruvananthapuram
  • E. Sreekumar, Director, Institute of Advanced Virology
  • Laboratory of Clinical and Epidemiological Virology, University of Leuven, Belgium

Multi-Dimensional Analysis

Political & Constitutional Dimensions:

From the government's perspective, the acquisition of PCR testing capability at IAV represents a proactive public health response to potential zoonotic disease emergence. The Health department's acknowledgment of hantavirus as a possible emerging pathogen demonstrates scientific temper and transparency in public health communication. The State government's investment in advanced virology infrastructure aligns with the broader One Health framework that India has been implementing.

From the opposition and public health advocacy viewpoint, the delayed establishment of diagnostic facilities—nearly 27 years after initial seropositivity was documented in 1999—raises questions about surveillance priorities. Critics argue that had active surveillance been initiated earlier, the true burden of hantavirus in Kerala could have been better understood. The fact that many cases remain documented as "unconfirmed/probable leptospirosis" for lack of timely diagnosis highlights systemic gaps in differential diagnosis capabilities. Article 47 of the Constitution directs the State to regard improvement of public health as among its primary duties.[/GK]

Economic & Financial Impact:

The economic implications are substantial. HFRS, with its 15% mortality rate in Southeast Asia, carries significant healthcare costs through extended hospitalizations, dialysis for acute kidney injury, and management of hemorrhagic complications. The similarity between leptospirosis and hantavirus symptoms means that inappropriate antibiotic treatment (effective against leptospirosis but not hantavirus) not only fails to treat the actual infection but also contributes to antimicrobial resistance and unnecessary healthcare expenditure.

Kerala's agricultural sector, particularly farming communities, faces occupational risk. The State's economy, heavily dependent on agriculture in certain regions, could see productivity losses if hantavirus emerges as a significant public health threat. The healthcare infrastructure investment in IAV represents a long-term public health security measure that could prevent larger economic losses from disease outbreaks.

Social Dimensions:

The social impact is most pronounced among high-risk occupational groups—farmers, sanitation workers, and those exposed to monsoon flooding. These communities already bear the burden of leptospirosis, and the possibility of co-infection with hantavirus compounds their health vulnerability. The December 2025 study's finding that 16.2% of febrile patients showed IgM positivity suggests significant community-level exposure.

Equity considerations arise because differential diagnosis requires sophisticated laboratory infrastructure available primarily in tertiary care centers. Rural populations, who are most exposed to rodent-borne diseases due to their occupational settings, may not have equal access to confirmatory testing. Dr. Aravind's observation that patients deteriorate and die within four to five days highlights the critical importance of timely diagnosis for survival outcomes.

Governance & Administrative Aspects:

The establishment of IAV and its PCR testing capability represents a significant strengthening of Kerala's public health laboratory infrastructure. However, implementation challenges remain. Serology tests have inherent limitations—detectable antibody levels may not appear during the acute phase of disease, and there are risks of hantavirus cross-reacting with other viruses, resulting in false negatives.

The federal structure of India's health system means that while States maintain public health facilities, the National Centre for Disease Control (NCDC) and Indian Council of Medical Research (ICMR) play coordinating roles in disease surveillance. The Integrated Disease Surveillance Programme (IDSP), launched in 2004, aims to strengthen disease surveillance for early epidemic detection.[/GK] The hantavirus situation underscores the need for better integration between State-level virology institutes and national surveillance frameworks.

The fact that Kerala has never conducted active surveillance for hantavirus despite documented serological evidence represents a governance gap. Moving forward, the challenge lies in establishing routine surveillance, training clinicians in differential diagnosis, and ensuring equitable access to diagnostic facilities across the State's healthcare network.

International Perspective:

Globally, hantavirus emergence is recognized as a One Health issue. The WHO's Global Health Sector Strategy on Viral Hepatitis and the One Health approach emphasize cross-sectoral collaboration for zoonotic disease control.[/GK] The collaboration with the University of Leuven, Belgium, in 1999 demonstrates the importance of international partnerships in addressing emerging pathogens.

Southeast Asian countries, particularly China and South Korea, have documented higher hantavirus prevalence and mortality. India's experience with HFRS, while less severe than in some neighboring countries, suggests the need for regional surveillance networks. The absence of human-to-human transmission (unlike some other hemorrhagic fevers) is a reassuring factor that simplifies containment strategies.

Way Forward

Short-Term Measures (0-12 months):

  • Expand PCR testing facilities beyond Thiruvananthapuram to all district hospitals and major tertiary care centers in Kerala to ensure equitable access
  • Conduct targeted training programs for clinicians on differential diagnosis of febrile illnesses with renal involvement, specifically distinguishing hantavirus-HFRS from leptospirosis
  • Establish sentinel surveillance sites in high-risk areas (agricultural zones, flood-prone regions) to monitor hantavirus circulation
  • Develop standardized clinical protocols for management of suspected hantavirus cases, including supportive care protocols for HFRS

Medium-Term Reforms (1-3 years):

  • Integrate hantavirus surveillance into the existing Integrated Disease Surveillance Programme (IDSP) framework with dedicated funding allocation
  • Establish a network of laboratories with hantavirus testing capability across the State, modeled on the successful IAV infrastructure
  • Conduct large-scale seroprevalence studies to determine the true burden of hantavirus infection in Kerala's population
  • Develop public health communication campaigns targeting high-risk occupational groups (farmers, sanitation workers) about rodent control and prevention measures

Long-Term Vision (3-5 years):

  • Strengthen the One Health approach by establishing formal coordination between human health, animal health (veterinary services), and environmental health departments for zoonotic disease surveillance
  • The National One Health Programme for Prevention and Control of Zoonoses, recommended by various expert committees, should be implemented with specific hantavirus surveillance components.[/GK]
  • Develop indigenous vaccine development research programs for hantavirus, drawing on international experience from countries like China where hantavirus vaccines are available
  • Establish a regional hantavirus surveillance network across South Asian Association for Regional Cooperation (SAARC) countries to monitor cross-border disease emergence

International Best Practices:

  • China: Established comprehensive hantavirus surveillance with rodent reservoir monitoring
  • South Korea: Developed clinical guidelines for HFRS management that could be adapted for Indian context
  • United States: The Sin Nombre virus outbreak in 1993 demonstrated the value of rapid diagnostic capability and inter-agency coordination

What can be asked in exam?

  • •Prelims angle: Hantavirus (Orthohantavirus) causes two major diseases: Hantavirus Pulmonary Syndrome and Hemorrhagic Fever with Renal Syndrome (HFRS), with HFRS being more common in India
  • •Prelims angle: The serotypes of hantavirus documented in Kerala (1999) were Seol virus (SEOV) and Puumala virus (PUUV)
  • •Prelims angle: HFRS due to hantavirus carries a reported mortality rate of up to 15% in Southeast Asia
  • •Mains angle: Analyze the challenges in differential diagnosis of clinically similar febrile illnesses like leptospirosis and hantavirus-induced HFRS in the context of India's public health laboratory infrastructure. (GS-III, 250 words)
  • •Mains angle: Discuss the significance of the One Health approach in addressing emerging zoonotic diseases like hantavirus, with reference to India's institutional framework. (GS-II, 250 words)

Test yourself · no signup needed

Attempt OPSC previous-year questions free

Try 3 real OPSC PYQs, see the answer instantly, then unlock the full set free.

OPSC PYQ 1 (2022) — Science

Genetic engineering, a revolutionary branch of biotechnology, continues to evolve rapidly, transforming the way we approach medicine, agriculture and various scientific endeavours. Recent developments in this field highlight both the immense potential and ethical considerations that come with the power to manipulate DNA. In the medical realm, gene editing technologies like CRISPR-Cas9 have gained prominence. These tools offer unprecedented precision in modifying genes, holding promise for treating genetic disorders. In a groundbreaking clinical trial, researchers successfully used gene editing to treat sickle cell anaemia. The patient’s own modified cells were reintroduced into their body, resulting in reduced symptoms and an improved quality of life. In agriculture, genetic engineering is driving advancements in crop production and food security. The development of Genetically Modified (GM) crops has enabled plants to resist pests, withstand harsh climates and improve nutritional content. For instance, GM rice has been biofortified to contain higher levels of essential vitamins, potentially combating malnutrition in regions where rice is a staple food. However, these advancements also raise ethical concerns. The potential for creating “designer babies” through gene editing has sparked debates about the boundaries of genetic manipulation. The question of whether it’s ethical to alter human DNA to enhance physical or cognitive traits continues to challenge bioethicists, policymakers and society at large. Data indicates the exponential growth of genetic engineering research. In the past decade, the number of scientific publications related to CRISPR technology has multiplied significantly. In 2010, there were approximately 150 CRISPR-related publications; by 2020, that number had soared to over 9,000. This surge demonstrates the profound impact of genetic engineering on the scientific community. As we navigate this brave new world of genetic engineering, striking a balance between innovation and ethical considerations remains paramount. The potential to cure genetic diseases, enhance food security and make leaps in scientific understanding is immense. However, careful consideration and collaboration are necessary to ensure that the benefits are realized while addressing the ethical complexities that accompany these technological breakthroughs.

Which gene editing technology has gained prominence recently?

  1. It is used for creating GM crops
  2. It is a tool for gene editing
  3. It enhances physical traits
  4. It is used in biofortification

Answer: A. It is used for creating GM crops

OPSC PYQ 2 (2022) — English Comprehension

EMBEZZLE

In the following question, choose the word which best expresses the meaning of the given word: EMBEZZLE

  1. Misappropriate
  2. Balance
  3. Remunerate
  4. Clear

Answer: A. Misappropriate

OPSC PYQ 3 (2023) — Reasoning

How many pairs of letters are there in the word 'CASTRAPHONE' which have as many letters between them in the word as in the alphabet?

  1. 3
  2. 4
  3. 5
  4. 6

Answer: D. 6

Free sample · Question 1 of 3

Science · 2022

Direction / Passage

Genetic engineering, a revolutionary branch of biotechnology, continues to evolve rapidly, transforming the way we approach medicine, agriculture and various scientific endeavours. Recent developments in this field highlight both the immense potential and ethical considerations that come with the power to manipulate DNA. In the medical realm, gene editing technologies like CRISPR-Cas9 have gained prominence. These tools offer unprecedented precision in modifying genes, holding promise for treating genetic disorders. In a groundbreaking clinical trial, researchers successfully used gene editing to treat sickle cell anaemia. The patient’s own modified cells were reintroduced into their body, resulting in reduced symptoms and an improved quality of life. In agriculture, genetic engineering is driving advancements in crop production and food security. The development of Genetically Modified (GM) crops has enabled plants to resist pests, withstand harsh climates and improve nutritional content. For instance, GM rice has been biofortified to contain higher levels of essential vitamins, potentially combating malnutrition in regions where rice is a staple food. However, these advancements also raise ethical concerns. The potential for creating “designer babies” through gene editing has sparked debates about the boundaries of genetic manipulation. The question of whether it’s ethical to alter human DNA to enhance physical or cognitive traits continues to challenge bioethicists, policymakers and society at large. Data indicates the exponential growth of genetic engineering research. In the past decade, the number of scientific publications related to CRISPR technology has multiplied significantly. In 2010, there were approximately 150 CRISPR-related publications; by 2020, that number had soared to over 9,000. This surge demonstrates the profound impact of genetic engineering on the scientific community. As we navigate this brave new world of genetic engineering, striking a balance between innovation and ethical considerations remains paramount. The potential to cure genetic diseases, enhance food security and make leaps in scientific understanding is immense. However, careful consideration and collaboration are necessary to ensure that the benefits are realized while addressing the ethical complexities that accompany these technological breakthroughs.

Which gene editing technology has gained prominence recently?

Continue with exam actions

Explore more in Science & TechnologyOpen 11 May digestAttempt OPSC PYQ — free, no signupAttempt MPPSC PYQ — free, no signup

This week's CA quiz · 20 questions

Cross-topic questions from recent current affairs

Start →

More on Science & Technology

Indian Astronomers Capture Blue Straggler Star Caught in the Act of Formation

28 Jul

DRDO Delivers India's First Indigenous 350-kg Thrust Expendable Turbojet Engine

27 Jul

DRDO's Indigenous 350-kg Thrust Turbojet Engine: A Big Leap for India's Missiles

25 Jul

Paninian's Yantur: India's First Private Indigenous Turbofan Engine Takes Flight

23 Jul

Study notes on Science & Technology

TNPSC · Chemistry

Free notes

MPPSC · Biology & Health

Free notes

UPSC · Places, Symbols & Miscellaneous

Free notes

WBCS · IT, AI & Emerging Technologies

Free notes